{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:37:41Z","timestamp":1794332261216,"version":"4.9.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.expneurol.2026.116078","type":"journal-article","created":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T14:17:05Z","timestamp":1792333025000},"page":"116078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A critical mechanistic synthesis of PINK1-mediated mitophagy signaling and its therapeutic targeting in Parkinson's disease neurodegeneration"],"prefix":"10.1016","volume":"408","author":[{"given":"Abida","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha","family":"Jawaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zia Ur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Kanan","family":"Alshammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Afroz","family":"Bakht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiyaz","family":"Shakeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Zawiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.expneurol.2026.116078_bb0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/cdd.2012.81","article-title":"The pathways of mitophagy for quality control and clearance of mitochondria","volume":"20","author":"Ashrafi","year":"2013","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.expneurol.2026.116078_bb0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12035-012-8245-1","article-title":"Primary skin fibroblasts as a model of Parkinson's disease","volume":"46","author":"Auburger","year":"2012","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.116078_bb0015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11130-022-01016-8","article-title":"Neuroprotective effects of Lycium barbarum fruit extract on Pink1(B9)Drosophila melanogaster genetic model of Parkinson's disease","volume":"78","author":"Bai","year":"2023","journal-title":"Plant Foods Human Nutrition (Dordrecht, Netherlands)"},{"key":"10.1016\/j.expneurol.2026.116078_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105401","article-title":"Intrafamilial and interfamilial heterogeneity of PINK1-associated Parkinson's disease in Sudan","volume":"111","author":"Bakhit","year":"2023","journal-title":"Parkinsonism Relat. Disord."},{"issue":"7","key":"10.1016\/j.expneurol.2026.116078_bb0025","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bbadis.2008.11.007","article-title":"Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis","volume":"1792","author":"Banerjee","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.expneurol.2026.116078_bb0030","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/cbic.201700500","article-title":"The anthelmintic drug Niclosamide and its analogues activate the Parkinson's disease associated protein kinase PINK1","volume":"19","author":"Barini","year":"2018","journal-title":"Chembiochem. Europ. J. Chem. Biol."},{"issue":"16","key":"10.1016\/j.expneurol.2026.116078_bb0035","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1073\/pnas.0500617102","article-title":"Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability","volume":"102","author":"Beilina","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2026.116078_bb0040","series-title":"A Double-blind, Randomised, Placebo-controlled, Rising Multiple-dose Study to Investigate the Tolerability and Steady-state Pharmacokinetics of BIA 6\u2013512 (Trans-resveratrol) in Healthy Volunteers","author":"Bial - Portela CSA","year":"2017"},{"issue":"16","key":"10.1016\/j.expneurol.2026.116078_bb0045","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf4888","article-title":"BBB opening with focused ultrasound in nonhuman primates and Parkinson's disease patients: targeted AAV vector delivery and PET imaging","volume":"9","author":"Blesa","year":"2023","journal-title":"Sci. Adv."},{"issue":"10","key":"10.1016\/j.expneurol.2026.116078_bb0050","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/hmg\/ddz004","article-title":"LRRK2 impairs PINK1\/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson's disease","volume":"28","author":"Bonello","year":"2019","journal-title":"Hum. Mol. Genet."},{"issue":"12","key":"10.1016\/j.expneurol.2026.116078_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101797","article-title":"Human dopaminergic neurons lacking PINK1 exhibit disrupted dopamine metabolism related to vitamin B6 co-factors","volume":"23","author":"Bus","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.expneurol.2026.116078_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1114231","article-title":"Mitochondria: it is all about energy","volume":"14","author":"Casanova","year":"2023","journal-title":"Front. Physiol."},{"issue":"11","key":"10.1016\/j.expneurol.2026.116078_bb0065","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1177\/0269881114550355","article-title":"Effects of cannabidiol in the treatment of patients with Parkinson's disease: an exploratory double-blind trial","volume":"28","author":"Chagas","year":"2014","journal-title":"J. Psychopharmacol. (Oxford, England)"},{"issue":"8","key":"10.1016\/j.expneurol.2026.116078_bb0070","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/nn.4593","article-title":"Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems","volume":"20","author":"Chan","year":"2017","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2026.116078_bb0075","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41392-023-01547-9","article-title":"Mitochondrial dynamics in health and disease: mechanisms and potential targets","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.expneurol.2026.116078_bb0080","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.stemcr.2016.08.012","article-title":"Parkin and PINK1 patient iPSC-derived midbrain dopamine neurons exhibit mitochondrial dysfunction and \u03b1-Synuclein accumulation","volume":"7","author":"Chung","year":"2016","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.expneurol.2026.116078_bb0090","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.REV120.014294","article-title":"Targeting mitophagy in Parkinson's disease","volume":"296","author":"Clark","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"7097","key":"10.1016\/j.expneurol.2026.116078_bb0085","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/nature04779","article-title":"Drosophila pink1 is required for mitochondrial function and interacts genetically with Parkin","volume":"441","author":"Clark","year":"2006","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.expneurol.2026.116078_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11092488","article-title":"Mitochondria and brain disease: a comprehensive review of pathological mechanisms and therapeutic opportunities","volume":"11","author":"Clemente-Su\u00e1rez","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.expneurol.2026.116078_bb0100","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.expneurol.2013.12.012","article-title":"PPAR\u03b3 activation rescues mitochondrial function from inhibition of complex I and loss of PINK1","volume":"253","author":"Corona","year":"2014","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.expneurol.2026.116078_bb0105","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbamcr.2010.08.007","article-title":"Mitophagy and Parkinson's disease: the PINK1-parkin link","volume":"1813","author":"Deas","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"19","key":"10.1016\/j.expneurol.2026.116078_bb0110","doi-asserted-by":"crossref","first-page":"E1817","DOI":"10.1073\/pnas.1305623110","article-title":"TFEB-mediated autophagy rescues midbrain dopamine neurons from \u03b1-synuclein toxicity","volume":"110","author":"Decressac","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.expneurol.2026.116078_bb0115","first-page":"504","article-title":"Parkinson's disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis","volume":"40","author":"DeMaagd","year":"2015","journal-title":"P & T"},{"issue":"45","key":"10.1016\/j.expneurol.2026.116078_bb0120","doi-asserted-by":"crossref","first-page":"12413","DOI":"10.1523\/JNEUROSCI.0719-07.2007","article-title":"Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin","volume":"27","author":"Exner","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2026.116078_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174262","article-title":"Inhibition of dynamin-related protein 1 ameliorates the mitochondrial ultrastructure via PINK1 and Parkin in the mice model of Parkinson's disease","volume":"907","author":"Feng","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.expneurol.2026.116078_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037564","article-title":"Dopamine induced neurodegeneration in a PINK1 model of Parkinson's disease","volume":"7","author":"Gandhi","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.expneurol.2026.116078_bb0130","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.molcel.2009.02.013","article-title":"PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death","volume":"33","author":"Gandhi","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.expneurol.2026.116078_bb0140","doi-asserted-by":"crossref","DOI":"10.1177\/20503121231157209","article-title":"Transcription factor EB as a key molecular factor in human health and its implication in diseases","volume":"11","author":"Gebrie","year":"2023","journal-title":"Sage Open Med."},{"key":"10.1016\/j.expneurol.2026.116078_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2022.107300","article-title":"Evaluation of curcumin as add-on therapy in patients with Parkinson's disease: a pilot randomized, triple-blind, placebo-controlled trial","volume":"218","author":"Ghodsi","year":"2022","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"9","key":"10.1016\/j.expneurol.2026.116078_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23094508","article-title":"Pathophysiological features of Nigral dopaminergic neurons in animal models of Parkinson's disease","volume":"23","author":"Guatteo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.expneurol.2026.116078_bb0155","first-page":"2003","article-title":"Oxidative stress, mitochondrial damage and neurodegenerative diseases","volume":"8","author":"Guo","year":"2013","journal-title":"Neural Regen. Res."},{"issue":"2","key":"10.1016\/j.expneurol.2026.116078_bb0165","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1021\/acs.nanolett.4c05186","article-title":"Peptide-functionalized lipid nanoparticles for targeted systemic mRNA delivery to the brain","volume":"25","author":"Han","year":"2025","journal-title":"Nano Lett."},{"issue":"20","key":"10.1016\/j.expneurol.2026.116078_bb0160","doi-asserted-by":"crossref","DOI":"10.1172\/JCI179633","article-title":"Deficiency of parkin causes neurodegeneration and accumulation of pathological \u03b1-synuclein in monkey models","volume":"134","author":"Han","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"17","key":"10.1016\/j.expneurol.2026.116078_bb0170","doi-asserted-by":"crossref","first-page":"7816","DOI":"10.1039\/D1FO00847A","article-title":"Gastrodin extends the lifespan and protects against neurodegeneration in the Drosophila PINK1 model of Parkinson's disease","volume":"12","author":"He","year":"2021","journal-title":"Food Funct."},{"issue":"1","key":"10.1016\/j.expneurol.2026.116078_bb0175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","article-title":"Mitochondrial dysfunction in Parkinson's disease - a key disease hallmark with therapeutic potential","volume":"18","author":"Henrich","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2026.116078_bb0185","series-title":"Pharmacological PINK1 Activation Ameliorates Pathology in Parkinson's Disease Models","author":"Hertz","year":"2024"},{"issue":"4","key":"10.1016\/j.expneurol.2026.116078_bb0180","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.cell.2013.07.030","article-title":"A neo-substrate that amplifies catalytic activity of parkinson's-disease-related kinase PINK1","volume":"154","author":"Hertz","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2026.116078_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1369014","article-title":"Detection of elevated levels of PINK1 in plasma from patients with idiopathic Parkinson's disease","volume":"16","author":"Hong","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.expneurol.2026.116078_bb0195","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neurobiolaging.2022.07.012","article-title":"Gene-based burden analysis of damaging private variants in PRKN, PARK7 and PINK1 in Parkinson's disease cohorts of European descent","volume":"119","author":"Hu","year":"2022","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.expneurol.2026.116078_bb0200","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/jnc.13412","article-title":"Mitochondrial and lysosomal biogenesis are activated following PINK1\/parkin-mediated mitophagy","volume":"136","author":"Ivankovic","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2026.116078_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.654340","article-title":"Cannabidiol induces autophagy to protects neural cells from mitochondrial dysfunction by upregulating SIRT1 to inhibits NF-\u03baB and NOTCH pathways","volume":"15","author":"Kang","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2026.116078_bb0210","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/716871","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"2011","author":"Keane","year":"2011","journal-title":"Parkinson's Disease"},{"issue":"1","key":"10.1016\/j.expneurol.2026.116078_bb0215","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbrc.2010.06.049","article-title":"Assessing the prevalence of PINK1 genetic variants in south African patients diagnosed with early- and late-onset Parkinson's disease","volume":"398","author":"Keyser","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"Pt B","key":"10.1016\/j.expneurol.2026.116078_bb0220","article-title":"Formoterol attenuated mitochondrial dysfunction in rotenone-induced Parkinson's disease in a rat model: role of PINK-1\/PARKIN and PI3K\/Akt\/CREB\/BDNF\/TrKB axis","volume":"125","author":"Khidr","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"27","key":"10.1016\/j.expneurol.2026.116078_bb0225","doi-asserted-by":"crossref","first-page":"11441","DOI":"10.1073\/pnas.0702717104","article-title":"Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice","volume":"104","author":"Kitada","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2026.116078_bb0230","doi-asserted-by":"crossref","DOI":"10.1038\/srep44373","article-title":"Nix restores mitophagy and mitochondrial function to protect against PINK1\/Parkin-related Parkinson's disease","volume":"7","author":"Koentjoro","year":"2017","journal-title":"Sci. Rep."},{"issue":"24","key":"10.1016\/j.expneurol.2026.116078_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413384","article-title":"Mitochondrial oxidative stress-a causative factor and therapeutic target in many diseases","volume":"22","author":"Kowalczyk","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.expneurol.2026.116078_bb0240","doi-asserted-by":"crossref","first-page":"354","DOI":"10.5483\/BMBRep.2022.55.7.040","article-title":"Inhibition of mitoNEET induces Pink1-Parkin-mediated mitophagy","volume":"55","author":"Lee","year":"2022","journal-title":"BMB Rep."},{"issue":"2","key":"10.1016\/j.expneurol.2026.116078_bb0245","first-page":"141","article-title":"Enhancing NAD+ salvage metabolism is neuroprotective in a PINK1 model of Parkinson's disease","volume":"6","author":"Lehmann","year":"2016","journal-title":"Biol. Open"},{"issue":"3","key":"10.1016\/j.expneurol.2026.116078_bb0250","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajhg.2016.01.014","article-title":"Loss of VPS13C function in autosomal-recessive parkinsonism causes mitochondrial dysfunction and increases PINK1\/Parkin-dependent Mitophagy","volume":"98","author":"Lesage","year":"2016","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.expneurol.2026.116078_bb0255","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.bbrc.2019.10.112","article-title":"Mitochondrial DNA heteroplasmy rises in substantial Nigra of aged PINK1 KO mice","volume":"521","author":"Li","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2026.116078_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112213","article-title":"Ginseng protein protects against mitochondrial dysfunction and neurodegeneration by inducing mitochondrial unfolded protein response in Drosophila melanogaster PINK1 model of Parkinson's disease","volume":"247","author":"Liu","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.expneurol.2026.116078_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2020.111212","article-title":"Mitochondrial fission and fusion: a dynamic role in aging and potential target for age-related disease","volume":"186","author":"Liu","year":"2020","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.expneurol.2026.116078_bb0270","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuint.2017.03.023","article-title":"Mitochondrial respiratory chain disorganization in Parkinson's disease-relevant PINK1 and DJ1 mutants","volume":"109","author":"Lopez-Fabuel","year":"2017","journal-title":"Neurochem. Int."},{"issue":"9","key":"10.1016\/j.expneurol.2026.116078_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26094451","article-title":"Mitochondrial dysfunction in genetic and non-genetic Parkinson's disease","volume":"26","author":"Lucchesi","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.expneurol.2026.116078_bb0280","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-021-00243-4","article-title":"Parkinson's disease\u2013associated VPS35 mutant reduces mitochondrial membrane potential and impairs PINK1\/Parkin-mediated mitophagy","volume":"10","author":"Ma","year":"2021","journal-title":"Transl. Neurodegener."},{"issue":"2","key":"10.1016\/j.expneurol.2026.116078_bb0285","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1083\/jcb.200910140","article-title":"PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy","volume":"189","author":"Matsuda","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2026.116078_bb0290","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/978-94-007-5416-4_16","article-title":"Parkinson's disease","volume":"65","author":"Mhyre","year":"2012","journal-title":"Subcell. Biochem."},{"issue":"2","key":"10.1016\/j.expneurol.2026.116078_bb0295","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/emmm.200900006","article-title":"Parkinson's disease mutations in PINK1 result in decreased complex I activity and deficient synaptic function","volume":"1","author":"Morais","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.expneurol.2026.116078_bb0300","article-title":"Mitochondrial dysfunction in Parkinson's disease: pathogenesis and neuroprotection","volume":"2011","author":"Mounsey","year":"2010","journal-title":"Parkinson's Disease"},{"issue":"11","key":"10.1016\/j.expneurol.2026.116078_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15112599","article-title":"Non-invasive drug delivery across the blood-brain barrier: a prospective analysis","volume":"15","author":"Niazi","year":"2023","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.expneurol.2026.116078_bb0310","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.neurobiolaging.2014.04.032","article-title":"Alpha-synuclein-induced neurodegeneration is exacerbated in PINK1 knockout mice","volume":"35","author":"Oliveras-Salv\u00e1","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"8","key":"10.1016\/j.expneurol.2026.116078_bb0315","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1021\/acs.jmedchem.6b01897","article-title":"Kinetin riboside and its ProTides activate the Parkinson's disease associated PTEN-induced putative kinase 1 (PINK1) independent of mitochondrial depolarization","volume":"60","author":"Osgerby","year":"2017","journal-title":"J. Med. Chem."},{"issue":"7097","key":"10.1016\/j.expneurol.2026.116078_bb0320","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nature04788","article-title":"Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by Parkin","volume":"441","author":"Park","year":"2006","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.expneurol.2026.116078_bb0325","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.tips.2018.02.007","article-title":"Cysteine metabolism in neuronal redox homeostasis","volume":"39","author":"Paul","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.expneurol.2026.116078_bb0330","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12640-018-9957-4","article-title":"Mutual antagonism of PINK1\/Parkin and PGC-1\u03b1 contributes to maintenance of mitochondrial homeostasis in rotenone-induced neurotoxicity","volume":"35","author":"Peng","year":"2019","journal-title":"Neurotox. Res."},{"issue":"5","key":"10.1016\/j.expneurol.2026.116078_bb0335","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1073\/pnas.0709336105","article-title":"The PINK1\/Parkin pathway regulates mitochondrial morphology","volume":"105","author":"Poole","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.expneurol.2026.116078_bb0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0050172","article-title":"PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1","volume":"5","author":"Pridgeon","year":"2007","journal-title":"PLoS Biol."},{"key":"10.1016\/j.expneurol.2026.116078_bb0345","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neuroscience.2022.07.007","article-title":"Age-related mitochondrial dysfunction in Parkinson's disease: new insights into the disease pathology","volume":"499","author":"Rani","year":"2022","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.expneurol.2026.116078_bb0350","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41531-018-0044-6","article-title":"Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson's disease","volume":"4","author":"Reeve","year":"2018","journal-title":"NPJ Parkinson's Disease"},{"issue":"41","key":"10.1016\/j.expneurol.2026.116078_bb0355","doi-asserted-by":"crossref","first-page":"36106","DOI":"10.1021\/acsnano.4c15013","article-title":"AI-validated brain targeted mRNA lipid nanoparticles with neuronal tropism","volume":"19","author":"Sela","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.expneurol.2026.116078_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102327","article-title":"ncRNAs and their impact on dopaminergic neurons: autophagy pathways in Parkinson's disease","volume":"98","author":"Thapa","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.expneurol.2026.116078_bb0365","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049727","article-title":"Increased cysteine metabolism in PINK1 models of Parkinson's disease","volume":"16","author":"Travaglio","year":"2023","journal-title":"Dis. Model. Mech."},{"issue":"2","key":"10.1016\/j.expneurol.2026.116078_bb0370","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/ncb2901","article-title":"Enhancing nucleotide metabolism protects against mitochondrial dysfunction and neurodegeneration in a PINK1 model of Parkinson's disease","volume":"16","author":"Tufi","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"5674","key":"10.1016\/j.expneurol.2026.116078_bb0375","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson's disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.expneurol.2026.116078_bb0380","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1007\/s12035-016-9843-0","article-title":"Curcumin rescues a PINK1 Knock down SH-SY5Y cellular model of Parkinson's disease from mitochondrial dysfunction and cell death","volume":"54","author":"van der Merwe","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.expneurol.2026.116078_bb0390","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41392-023-01503-7","article-title":"The mitophagy pathway and its implications in human diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.expneurol.2026.116078_bb0385","doi-asserted-by":"crossref","first-page":"11738","DOI":"10.18632\/aging.202868","article-title":"Administration of quercetin improves mitochondria quality control and protects the neurons in 6-OHDA-lesioned Parkinson's disease models","volume":"13","author":"Wang","year":"2021","journal-title":"Aging"},{"issue":"24","key":"10.1016\/j.expneurol.2026.116078_bb0395","doi-asserted-by":"crossref","first-page":"25035","DOI":"10.18632\/aging.103970","article-title":"\u03b4-Opioid receptor activation protects against Parkinson's disease-related mitochondrial dysfunction by enhancing PINK1\/Parkin-dependent mitophagy","volume":"12","author":"Xu","year":"2020","journal-title":"Aging"},{"issue":"4","key":"10.1016\/j.expneurol.2026.116078_bb0400","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.bbrc.2017.12.149","article-title":"LncRNA NEAT1 promotes autophagy in MPTP-induced Parkinson's disease through stabilizing PINK1 protein","volume":"496","author":"Yan","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.expneurol.2026.116078_bb0405","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2020.11711","article-title":"Resveratrol alleviates oxygen\/glucose deprivation\/reoxygenation-induced neuronal damage through induction of mitophagy","volume":"23","author":"Ye","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.expneurol.2026.116078_bb0410","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/108029","article-title":"Mitochondrial dysfunction and \u03b1-Synuclein synaptic pathology in Parkinson's disease: who's on first?","volume":"2015","author":"Zaltieri","year":"2015","journal-title":"Parkinson's Disease"},{"issue":"39","key":"10.1016\/j.expneurol.2026.116078_bb0415","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abp8701","article-title":"Ca(2+) channels couple spiking to mitochondrial metabolism in substantia nigra dopaminergic neurons","volume":"8","author":"Zampese","year":"2022","journal-title":"Sci. Adv."},{"issue":"14","key":"10.1016\/j.expneurol.2026.116078_bb0420","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1093\/hmg\/ddt132","article-title":"TRAP1 rescues PINK1 loss-of-function phenotypes","volume":"22","author":"Zhang","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.expneurol.2026.116078_bb0425","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-026-01443-3","article-title":"Loss of PINK1 causes age-dependent mitochondrial trafficking deficits in nigrostriatal dopaminergic neurons through aberrant activation of p38 MAPK","volume":"12","author":"Zhao","year":"2026","journal-title":"NPJ Parkinsons Dis."},{"issue":"12","key":"10.1016\/j.expneurol.2026.116078_bb0430","doi-asserted-by":"crossref","first-page":"e2501","DOI":"10.1038\/cddis.2016.396","article-title":"PINK1-dependent phosphorylation of PINK1 and Parkin is essential for mitochondrial quality control","volume":"7","author":"Zhuang","year":"2016","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.expneurol.2026.116078_bb0435","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1152\/physrev.00026.2013","article-title":"Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release","volume":"94","author":"Zorov","year":"2014","journal-title":"Physiol. Rev."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626004462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626004462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:04:26Z","timestamp":1794330266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488626004462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":87,"alternative-id":["S0014488626004462"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.116078","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A critical mechanistic synthesis of PINK1-mediated mitophagy signaling and its therapeutic targeting in Parkinson's disease neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.116078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116078"}}